Advances in transplantation tolerance.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  The Lancet

• Publication date

  2001-06-16

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0140-6736(00)05068-6PMID 11425437
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects.

  2001cited by this paper
• Anti-CD3ε F(ab′)2 Prevents Graft-Versus-Host Disease by Selectively Depleting Donor T Cells Activated by Recipient Alloantigens1

  2001cited by this paper
• p27kip1 functions as an anergy factor inhibiting interleukin 2 transcription and clonal expansion of alloreactive human and mouse helper T lymphocytes

  2000cited by this paper
• Immunologic Self-Tolerance Maintained by Cd25+Cd4+Regulatory T Cells Constitutively Expressing Cytotoxic T Lymphocyte–Associated Antigen 4

  2000cited by this paper
• Twelve years' experience with national sharing of HLA-matched cadaveric kidneys for transplantation.

  2000cited by this paper
• Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo

  2000cited by this paper
• Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. The Rapamune US Study Group.

  2000cited by this paper
• Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.

  2000cited by this paper
• Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation.

  2000cited by this paper
• Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment

  2000cited by this paper
• CD28-Specific Antibody Prevents Graft-Versus-Host Disease in Mice1

  2000cited by this paper
• Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

  2000cited by this paper
• Compromised kidney graft rejection response in Vervet monkeys after withdrawal of immunosuppressants tacrolimus and sirolimus.

  2000cited by this paper
• Non-Fc Receptor-Binding Humanized Anti-CD3 Antibodies Induce Apoptosis of Activated Human T Cells1

  2000cited by this paper
• Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment.

  1999cited by this paper
• Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates

  1999cited by this paper
• Prevention of graft versus host disease by inactivation of host antigen-presenting cells.

  1999cited by this paper
• Dendritic cells as regulators of immune reactivity: implications for transplantation.

  1999cited by this paper
• Mycophenolate mofetil in renal transplantation: 3-year results from the placebo-controlled trial. European Mycophenolate Mofetil Cooperative Study Group.

  1999cited by this paper
• Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation.

  1999cited by this paper
• Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance

  1999cited by this paper
• Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance

  1999cited by this paper
• Infusion of donor leukocytes to induce tolerance in organ allograft recipients

  1999cited by this paper
• Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation.

  1999cited by this paper
• Cytotoxic T Lymphocyte Antigen 4 (CTLA4) Blockade Accelerates the Acute Rejection of Cardiac Allografts in CD28-deficient Mice: CTLA4 Can Function Independently of CD28

  1998cited by this paper
• A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell

  1998cited by this paper
• Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype.

  1998cited by this paper
• Role of CD28 in acute graft-versus-host disease.

  1998cited by this paper
• Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group.

  1998cited by this paper
• Interleukin-2-Receptor Blockade With Daclizumab to Prevent Acute Rejection in Renal Transplantation

  1998cited by this paper
• Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement.

  1997cited by this paper
• Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group.

  1997cited by this paper
• Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation.

  1997cited by this paper
• The male-specific histocompatibility antigen, H-Y: a history of transplantation, immune response genes, sex determination and expression cloning.

  1997cited by this paper
• Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation.

  1997cited by this paper
• CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates.

  1997cited by this paper
• Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection - A report of the European Tacrolimus Multicenter Renal Study Group

  1997cited by this paper
• Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways

  1996cited by this paper
• CD28/B7 system of T cell costimulation.

  1996cited by this paper
• CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL.

  1995cited by this paper
• Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand

  1995cited by this paper
• Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4

  1995cited by this paper
• lnterleukin-2-mediated elimination of the p27Kipl cyclin-dependent kinase inhibitor prevented by rapamycin

  1994cited by this paper
• T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis.

  1994cited by this paper
• Differential T cell costimulatory requirements in CD28-deficient mice.

  1993cited by this paper
• The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome.

  1993cited by this paper
• Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1

  1993cited by this paper
• Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg.

  1992cited by this paper
• CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones

  1992cited by this paper
• Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis.

  1991cited by this paper
• lnterleukin-2 programs mouse αβ T lymphocytes for apoptosis

  1991cited by this paper
• Self-nonself discrimination by T cells.

  1990cited by this paper
• A cell culture model for T lymphocyte clonal anergy.

  1990cited by this paper
• T cell tolerance by clonal elimination in the thymus.

  1987cited by this paper
• Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance

  1986cited by this paper
• Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts

  1984cited by this paper
• Cyclosporin a as sole immunosuppressive agent in recipients of kidney allografts from cadaver donors. Preliminary results of a European multicentre trial.

  1982cited by this paper
• Activation of transplant immunity: effect of donor leukocytes on thyroid allograft rejection.

  1976cited by this paper
• Anti‐lymphocytic antibodies and marrow transplantation. III. Effect of heterologous anti‐brain antibodies on acute secondary disease in mice

  1974cited by this paper

• Unlocking Transplant Tolerance with Biomaterials

  2024cites this paper
• Safety and efficacy of allogenic human amniotic epithelial cells transplantation via ovarian artery in patients with premature ovarian failure: a single-arm, phase 1 clinical trial

  2024cites this paper
• Gut microbes enlarged the protective effect of transplanted regulatory B cells on rejection of cardiac allografts.

  2021cites this paper
• Adaptive Immunotherapy for Opportunistic Infections

  2019cites this paper
• Die gezielte Beeinflussung der Immunantwort

  2018cites this paper
• In Utero Hepatocellular Transplantation in Rats

  2013cites this paper
• immunoreactive T cells P-glycoprotein targeting: a unique strategy to selectively eliminate

  2013cites this paper
• Composite Tissue Allotransplantation Immunology

  2013cites this paper
• memory phenotype cytolytic cells that lack TCR Signaling through MHC in transgenic mice generates a population of

  2013cites this paper
• Targeting LKB1 signaling in cancer.

  2013cites this paper
• Single-Agent Immunosuppression After Liver Transplantation

  2012cites this paper
• Influence of immunosuppressive agents on tryptophan degradation and neopterin production in human peripheral blood mononuclear cells.

  2011cites this paper
• Synthesis of N-aryl-3-(indol-3-yl)propanamides and their immunosuppressive activities.

  2010cites this paper
• Cryopreservation and the age of the allotransplant

  2009cites this paper
• Immunosuppressive Withanolides from Withania coagulans

  2009cites this paper
• Basics of Immune Responses in Transplantation in Preparation for Application of Composite Tissue Allografts in Plastic and Reconstructive Surgery: Part I

  2008cites this paper
• Synthetic N-pyridinyl(methyl)-indol-3-ylpropanamides as new potential immunosuppressive agents.

  2007cites this paper
• Increased expression of CD 154 ( CD 40 L ) on stimulated T-cells from patients with psoriatic arthritis

  2007cites this paper
• Frontiers in nephrology: T cell memory as a barrier to transplant tolerance.

  2007cites this paper
• Pathways of T-cell costimulation

  2007cites this paper
• Increased expression of CD154 (CD40L) on stimulated T-cells from patients with psoriatic arthritis.

  2006cites this paper
• Defect of oral tolerance in NC/Nga mice.

  2006cites this paper
• T regulatory cells as an immunotherapy for transplantation

  2006cites this paper
• Rapamycin (sirolimus) as a steroid-sparing agent in dermatomyositis.

  2005cites this paper
• A new carboxamide compound exerts immuno‐suppressive activity by inhibiting dendritic cell maturation

  2005cites this paper
• Elimination of alloreactive T cells using photodynamic therapy.

  2005cites this paper
• The frequency of interleukin-10- and interleukin-5-secreting CD4+ T cells correlates to tolerance of transplanted lung.

  2005cites this paper
• Antigen‐dependent suppression of alloresponses by Foxp3‐induced regulatory T cells in transplantation

  2005cites this paper
• Targeting CD40L: a Promising Therapeutic Approach

  2004cites this paper
• Anti-CD40 Ligand Therapy Despite Donor-Specific Transfusion and T Cells Remain Intact + Memory CD4 In Vivo Helper Functions of Alloreactive

  2004cites this paper
• Potential of colony-stimulating factors to improve host defense in organ transplant recipients

  2004cites this paper
• Animal models in uveal melanoma: establishment and research.

  2004cites this paper
• Strategies for Antigen-Specific Immunomodulation in Experimental Organ Transplantation

  2004cites this paper
• In vivo IL‐10 and TGF‐β production by PBMC from long‐term kidney transplant recipients with excellent graft function: a possible feedback mechanism participating in immunological stability

  2004cites this paper
• Neonatal tolerance revisited again: specific CTL priming in mouse neonates exposed to small numbers of semi‐ or fully allogeneic spleen cells

  2004cites this paper
• Experimental limb transplantation, part II: excellent return of function and indefinite survival after withdrawal of immunosuppression.

  2004cites this paper
• Donor bone marrow transplantation: chimerism and tolerance.

  2004cites this paper
• The potential of GM-CSF to improve resistance against infections in organ transplantation.

  2004cites this paper
• In Vivo Helper Functions of Alloreactive Memory CD4+ T Cells Remain Intact Despite Donor-Specific Transfusion and Anti-CD40 Ligand Therapy1

  2004cites this paper
• Immunology in Pancreas Transplantation

  2004cites this paper
• MINIREVIEWS Targeting CD40L: a Promising Therapeutic Approach

  2004cites this paper
• Mobilizing dendritic cells for tolerance by engagement of immune inhibitory receptors for HLA-G.

  2003cites this paper
• Nonmyeloablative alternative donor transplants

  2003cites this paper
• Sirolimus therapy in cardiac transplantation.

  2003cites this paper
• Influence of intrauterine injection of rat fetal hepatocytes on rejection of rat liver transplantation.

  2003cites this paper
• Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody.

  2003cites this paper
• Osteoporosis after liver transplantation

  2003cites this paper
• Steroid‐refractory graft‐vs.‐host disease: past, present and future

  2003cites this paper
• Antigen-specific, CD4+CD25+ regulatory T cell clones induced in Peyer's patches.

  2003cites this paper
• Treatment with humanized monoclonal antibodies against CD80 and CD86 combined with sirolimus prolongs renal allograft survival in cynomolgus monkeys1

  2003cites this paper
• Public stem cell banks: considerations of justice in stem cell research and therapy.

  2003cites this paper
• Overexpression of the Notch ligand, Jagged-1, induces alloantigen-specific human regulatory T cells.

  2003cites this paper
• Nonhuman Primate Models of Hematopoietic Stem Cell Transplantation

  2003cites this paper
• Signaling through MHC in transgenic mice generates a population of memory phenotype cytolytic cells that lack TCR.

  2003cites this paper
• In remembrance of things past: memory T cells and transplant rejection

  2003cites this paper
• Urinary amino-terminal propeptide of type III procollagen (PIIINP) as a marker of interstitial fibrosis in renal transplant recipients

  2003cites this paper
• DENDRITIC CELLS AND SECOND SIGNAL BLOCKADE: A STEP TOWARD ALLOGRAFT TOLERANCE?

  2002cites this paper
• Single-agent immunosuppression after liver transplantation: what is possible?

  2002cites this paper
• Selective Reconstitution by GM-CSF of the Immune Response in Human Immunosuppressed Cells

  2002cites this paper
• Selective Reconstitution by GM-CSF of the Immune Response in Human Immunosuppressed Cells

  2002cites this paper
• Emerging evidence that molecules expressed by mammalian tissue grafts are recognized by the innate immune system

  2002cites this paper
• P-glycoprotein targeting: a unique strategy to selectively eliminate immunoreactive T cells.

  2002cites this paper
• Xenotransplantation in the 21st Century

  2002cites this paper